发明名称 SUBSTITUTED NORBORNYLAMINO DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT OR A DIAGNOSTIC REAGENT AND MEDICAMENTS CONTAINING SAID COMPOUNDS
摘要 The invention relates to substituted norbornylamino derivatives containing e xo- configured nitrogen and an endo-annellated pentacyclic ring of formula (I) a nd exo-configured nitrogen and an exo-annellated pentacyclic ring of formula (Ia), wherein R1, R2 R3, R4, R5, A, B, S1 and S2 have the meanings cited in the claims. Said derivatives are especially suitable as anti-hypertensive agents for reducing or preventing ischaemia-induced damage, as medicaments f or use in surgical procedures for treating ischaemias of the nervous system, of a cerebrovascular accident and of a cerebral oedema. The derivatives are also suitable for treating shock, an impaired respiratory impulse, snoring, or fo r use as a laxative, as an agent against ectoparasites, in the prophylaxis of gall stones, as an anti-atherosclerotic agent, as an agent for treating late complications of diabetes, or for treating cancerous illnesses, fibrotic disorders, endothelial dysfunction and organ hypertrophies and hyperplasias. Said derivatives act as inhibitors of the cellular sodium-proton-antiporter. They also influence serum lipoproteins and can thus be used in the prophylax is and reversal of atherosclerotic changes.
申请公布号 CA2394130(A1) 申请公布日期 2001.06.21
申请号 CA20002394130 申请日期 2000.12.01
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH 发明人 JANSEN, HANS-WILLI;HEINELT, UWE;WIRTH, KLAUS;LANG, HANS JOCHEN;SCHWARK, JAN-ROBERT;KLEEMANN, HEINZ-WERNER
分类号 C07D317/58;A61K31/135;A61K31/14;A61K31/155;A61K31/166;A61K31/18;A61K31/24;A61K31/277;A61K31/36;A61K31/713;A61P1/00;A61P1/10;A61P1/16;A61P3/00;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P11/00;A61P13/08;A61P13/12;A61P25/00;A61P25/28;A61P33/00;A61P37/06;C07C209/08;C07C209/28;C07C211/38;C07C211/49;C07C215/28;C07C215/30;C07C217/58;C07C217/60;C07C217/62;C07C227/18;C07C229/38;C07C237/30;C07C253/30;C07C255/58;C07C257/18;C07C311/37;C07C317/32;C07C323/32;(IPC1-7):C07C211/38;A61K31/137;C07C217/56 主分类号 C07D317/58
代理机构 代理人
主权项
地址